Basal cell carcinoma

Mordechai Rosner; Ido Didi Fabian

doi:10.1007/978-3-642-38336-6_4

Basal cell carcinoma

Mordechai Rosner^*, Ido Didi Fabian

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Basal cell carcinoma (BCC) is a malignant cutaneous neoplasm capable of extensive tissue destruction. It is often observed on the head and neck, and the eyelids are a common location. BCC was initially described as a distinct entity by Krompecher [1] at the beginning of the twentieth century. Some authorities preferred the term “epithelioma” to carcinoma because of the tumor’s limited capacity to metastasize [1]. While the mortality from BCC is low, the morbidity may be considerable.

Original language	English
Title of host publication	Clinical Ophthalmic Oncology
Subtitle of host publication	Eyelid and Conjunctival Tumors
Publisher	Springer Berlin Heidelberg
Pages	33-42
Number of pages	10
ISBN (Electronic)	9783642383366
ISBN (Print)	9783642383359
DOIs	https://doi.org/10.1007/978-3-642-38336-6_4
State	Published - 1 Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-642-38336-6_4

Cite this

@inbook{a7299c23db944b54b8c14178ed187a97,

title = "Basal cell carcinoma",

abstract = "Basal cell carcinoma (BCC) is a malignant cutaneous neoplasm capable of extensive tissue destruction. It is often observed on the head and neck, and the eyelids are a common location. BCC was initially described as a distinct entity by Krompecher [1] at the beginning of the twentieth century. Some authorities preferred the term “epithelioma” to carcinoma because of the tumor{\textquoteright}s limited capacity to metastasize [1]. While the mortality from BCC is low, the morbidity may be considerable.",

author = "Mordechai Rosner and Fabian, {Ido Didi}",

note = "Publisher Copyright: {\textcopyright} Springer-Verlag Berlin Heidelberg 2014.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-3-642-38336-6_4",

language = "אנגלית",

isbn = "9783642383359",

pages = "33--42",

booktitle = "Clinical Ophthalmic Oncology",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Basal cell carcinoma

AU - Rosner, Mordechai

AU - Fabian, Ido Didi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Basal cell carcinoma (BCC) is a malignant cutaneous neoplasm capable of extensive tissue destruction. It is often observed on the head and neck, and the eyelids are a common location. BCC was initially described as a distinct entity by Krompecher [1] at the beginning of the twentieth century. Some authorities preferred the term “epithelioma” to carcinoma because of the tumor’s limited capacity to metastasize [1]. While the mortality from BCC is low, the morbidity may be considerable.

AB - Basal cell carcinoma (BCC) is a malignant cutaneous neoplasm capable of extensive tissue destruction. It is often observed on the head and neck, and the eyelids are a common location. BCC was initially described as a distinct entity by Krompecher [1] at the beginning of the twentieth century. Some authorities preferred the term “epithelioma” to carcinoma because of the tumor’s limited capacity to metastasize [1]. While the mortality from BCC is low, the morbidity may be considerable.

UR - http://www.scopus.com/inward/record.url?scp=84956466418&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-38336-6_4

DO - 10.1007/978-3-642-38336-6_4

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:84956466418

SN - 9783642383359

SP - 33

EP - 42

BT - Clinical Ophthalmic Oncology

PB - Springer Berlin Heidelberg

ER -

Basal cell carcinoma

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this